Compared with CP alone, the administration of all three doses (PD-L, PD-M, and PD-H) reduced BUN (Figure 5(f)) and Scr (Figure 5(g)) in CP-AKI mice, in which PD-M was the best (reaching about 27.8% and 28.1% of the CP group). The gene discussed is CP; the disease is acute kidney injury.